SG4995G - Controlled release pharmaceutical preparation - Google Patents

Controlled release pharmaceutical preparation

Info

Publication number
SG4995G
SG4995G SG4995A SG4995A SG4995G SG 4995 G SG4995 G SG 4995G SG 4995 A SG4995 A SG 4995A SG 4995 A SG4995 A SG 4995A SG 4995 G SG4995 G SG 4995G
Authority
SG
Singapore
Prior art keywords
controlled release
pharmaceutical preparation
release pharmaceutical
water
medicinal compound
Prior art date
Application number
SG4995A
Other languages
English (en)
Inventor
Kazuo Noda
Takashi Osawa
Masao Kobayashi
Shigeyuki Ishikawa
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26494375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG4995(G) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to JP3138998A priority Critical patent/JP2558396B2/ja
Priority to FI912952A priority patent/FI103476B/fi
Priority to IE216691A priority patent/IE64629B1/en
Priority to AU79243/91A priority patent/AU634400C/en
Priority to CA002045358A priority patent/CA2045358C/fr
Priority to IL9861191A priority patent/IL98611A/en
Priority to DK91305834.3T priority patent/DK0463877T3/da
Priority to DE69102211T priority patent/DE69102211T3/de
Priority to EP91305834A priority patent/EP0463877B2/fr
Priority to ES91305834T priority patent/ES2055962T5/es
Priority to HU912170A priority patent/HU214590B/hu
Priority to AT91305834T priority patent/ATE106241T1/de
Priority to CN91105399A priority patent/CN1040061C/zh
Priority to US07/723,031 priority patent/US5137733A/en
Priority to KR1019910010955A priority patent/KR0133511B1/ko
Priority to SG4995A priority patent/SG4995G/en
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Priority to HK33895A priority patent/HK33895A/xx
Publication of SG4995G publication Critical patent/SG4995G/en
Priority to GR970402109T priority patent/GR3024471T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Stringed Musical Instruments (AREA)
  • Pens And Brushes (AREA)
SG4995A 1990-06-28 1995-01-13 Controlled release pharmaceutical preparation SG4995G (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
JP3138998A JP2558396B2 (ja) 1990-06-28 1991-06-11 放出制御型製剤
FI912952A FI103476B (fi) 1990-06-28 1991-06-18 Säädellysti lääkeainetta vapauttavan farmaseuttisen valmisteen valmist usmenetelmä
IE216691A IE64629B1 (en) 1990-06-28 1991-06-21 Controlled release pharmaceutical preparation
AU79243/91A AU634400C (en) 1990-06-28 1991-06-24 Controlled release pharmaceutical preparation
CA002045358A CA2045358C (fr) 1990-06-28 1991-06-25 Preparation pharmaceutique a liberation prolongee
IL9861191A IL98611A (en) 1990-06-28 1991-06-25 Pharmacological preparations with controlled release
ES91305834T ES2055962T5 (es) 1990-06-28 1991-06-27 Preparado farmaceutico de liberacion controlada.
DE69102211T DE69102211T3 (de) 1990-06-28 1991-06-27 Pharmazeutische Zubereitung mit kontrollierter Freigabe.
EP91305834A EP0463877B2 (fr) 1990-06-28 1991-06-27 Préparation pharmaceutique à libération contrÔlée
DK91305834.3T DK0463877T3 (da) 1990-06-28 1991-06-27 Farmaceutisk præparat med kontrolleret frigivelse
HU912170A HU214590B (hu) 1990-06-28 1991-06-27 Eljárás ellenőrzött hatóanyag-felszabadítású gyógyszerkészítmények előállítására
AT91305834T ATE106241T1 (de) 1990-06-28 1991-06-27 Pharmazeutische zubereitung mit kontrollierter freigabe.
US07/723,031 US5137733A (en) 1990-06-28 1991-06-28 Controlled release pharmaceutical preparation
CN91105399A CN1040061C (zh) 1990-06-28 1991-06-28 控释药物制剂的制备方法
KR1019910010955A KR0133511B1 (ko) 1990-06-28 1991-06-28 방출 제어성 약학 제제
SG4995A SG4995G (en) 1990-06-28 1995-01-13 Controlled release pharmaceutical preparation
HK33895A HK33895A (en) 1990-06-28 1995-03-09 Controlled release pharmaceutical preparation
GR970402109T GR3024471T3 (en) 1990-06-28 1997-08-14 Controlled release pharmaceutical preparation.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17176290 1990-06-28
SG4995A SG4995G (en) 1990-06-28 1995-01-13 Controlled release pharmaceutical preparation

Publications (1)

Publication Number Publication Date
SG4995G true SG4995G (en) 1995-06-16

Family

ID=26494375

Family Applications (1)

Application Number Title Priority Date Filing Date
SG4995A SG4995G (en) 1990-06-28 1995-01-13 Controlled release pharmaceutical preparation

Country Status (17)

Country Link
US (1) US5137733A (fr)
EP (1) EP0463877B2 (fr)
JP (1) JP2558396B2 (fr)
KR (1) KR0133511B1 (fr)
CN (1) CN1040061C (fr)
AT (1) ATE106241T1 (fr)
CA (1) CA2045358C (fr)
DE (1) DE69102211T3 (fr)
DK (1) DK0463877T3 (fr)
ES (1) ES2055962T5 (fr)
FI (1) FI103476B (fr)
GR (1) GR3024471T3 (fr)
HK (1) HK33895A (fr)
HU (1) HU214590B (fr)
IE (1) IE64629B1 (fr)
IL (1) IL98611A (fr)
SG (1) SG4995G (fr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5286493A (en) * 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US7070806B2 (en) 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
CN1053808C (zh) * 1993-04-24 2000-06-28 章修纲 尼非地平控释剂型
JP2916978B2 (ja) * 1993-08-25 1999-07-05 エスエス製薬株式会社 放出開始制御型製剤
US5834024A (en) 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
US6962997B1 (en) * 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
CA2270975C (fr) 1997-07-02 2003-04-01 Euro-Celtique, S.A. Formulations de tramadol stabilisees a liberation prolongee
AU2546399A (en) 1998-02-10 1999-08-30 Yoshitomi Pharmaceutical Industries, Ltd. Preparations with controlled release
FR2778848B1 (fr) * 1998-05-20 2001-11-23 Prographarm Lab Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
US6322819B1 (en) 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
US6270805B1 (en) 1998-11-06 2001-08-07 Andrx Pharmaceuticals, Inc. Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate
US6039979A (en) * 1999-01-13 2000-03-21 Laboratoires Prographarm Multiparticulate pharmaceutical form with programmed and pulsed release and process for its preparation
US6733789B1 (en) 1999-01-21 2004-05-11 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
CA2359709A1 (fr) * 1999-01-21 2000-07-27 Elan Corporation, Plc Formulation de bisoprolol multiparticulaire
EP1712222A3 (fr) 1999-12-23 2012-06-20 Pfizer Products Inc. Compositions pharmaceutiques fournissant des concentrations de médicaments améliorées
CN1402632A (zh) * 1999-12-23 2003-03-12 辉瑞产品公司 水凝胶驱动的药物剂型
US20040185099A1 (en) * 2000-01-20 2004-09-23 Biovail Laboratories, Inc. Multiparticulate bisoprolol formulation
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
US6984402B2 (en) 2000-10-03 2006-01-10 Elite Laboratories, Inc. Chrono delivery formulations and method of treating atrial fibrillation
US6620439B1 (en) * 2000-10-03 2003-09-16 Atul M. Mehta Chrono delivery formulations and method of use thereof
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
WO2002094172A2 (fr) * 2001-05-22 2002-11-28 Euro-Celtique Forme posologique compartimentee
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US20030091633A1 (en) * 2001-11-15 2003-05-15 John Kelly Methods and compositions for use of (S)-bisoprolol
US20030118652A1 (en) * 2001-11-15 2003-06-26 John Kelly Methods and compositions for use of (S)-bisoprolol
US6663888B2 (en) 2001-12-14 2003-12-16 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
US20050025824A1 (en) * 2001-12-14 2005-02-03 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
EP1607405B1 (fr) * 2003-03-11 2011-05-04 Seikagaku Corporation Composition polysaccharide photoreticulee et procede de fabrication
ATE512659T1 (de) 2003-04-24 2011-07-15 Jagotec Ag Tablette mit verzögerter wirkstofffreigabe und bestimmter formgeometrie
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
EP1759719B1 (fr) * 2004-05-07 2015-01-07 Seikagaku Corporation Matière de remplissage de nucleus pulposus
DE102004043863A1 (de) 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
AU2005313887B2 (en) * 2004-12-09 2011-10-27 Celgene Corporation Treatment using D-threo methylphenidate
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US8846100B2 (en) * 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
SI2049123T1 (sl) 2006-08-03 2013-04-30 Horizon Pharma Ag Zdravljenje revmatoznih bolezni z zadržanim sproščanjem glukokortikoida
JP2008024708A (ja) * 2007-08-20 2008-02-07 Euro-Celtique Sa アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法
EP2358360B1 (fr) * 2008-11-18 2016-09-14 UCB Biopharma SPRL Formules à libération prolongée comprenant un dérivé de 2-oxo-1-pyrrolidine
CN101904813A (zh) * 2009-04-22 2010-12-08 苏维拉克皮肤及健康护理公司 冻干包衣的模制品
ES2668203T3 (es) 2009-12-02 2018-05-17 Adare Pharmaceuticals S.R.L. Microcápsulas de fexofenadina y composiciones que las contienen
KR101698041B1 (ko) * 2010-12-03 2017-01-19 닛뽕소다 가부시키가이샤 하이드록시알킬셀룰로오스
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
DK2688557T3 (da) 2011-03-23 2017-11-27 Ironshore Pharmaceuticals & Dev Inc Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
JP5146859B2 (ja) * 2011-07-11 2013-02-20 ユーロ−セルティーク エス．エイ． アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法
CA2936746C (fr) 2014-10-31 2017-06-27 Purdue Pharma Methodes et compositions destinees au traitement du trouble de deficit d'attention
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944311A (ja) * 1982-09-07 1984-03-12 Santen Pharmaceut Co Ltd 徐放性顆粒およびその製造法
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
US5002776A (en) * 1983-12-22 1991-03-26 Elan Corporation, Plc Controlled absorption diltiazem formulations
US4559225A (en) * 1984-02-16 1985-12-17 Fourman Robert G Sunscreen composition
JPH0621066B2 (ja) * 1984-03-14 1994-03-23 杏林製薬株式会社 ３―イソブチリル―２―イソプロピルピラゾロ〔１，５―ａ〕ピリジンの徐放性医薬品組成物
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
DK0386440T3 (da) * 1989-02-11 1992-09-14 Bayer Ag Lægemidler med kontrolleret afgivelse af virksomt stof
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings
US5013557A (en) * 1989-10-03 1991-05-07 Warner-Lambert Company Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same
JPH0674206B2 (ja) * 1989-12-28 1994-09-21 田辺製薬株式会社 放出制御型製剤およびその製法

Also Published As

Publication number Publication date
CN1058533A (zh) 1992-02-12
AU634400B2 (en) 1993-02-18
DE69102211T3 (de) 1997-08-28
FI912952A (fi) 1991-12-29
HU912170D0 (en) 1991-12-30
JPH04235123A (ja) 1992-08-24
CA2045358C (fr) 1998-04-28
ES2055962T3 (es) 1994-09-01
HK33895A (en) 1995-03-17
FI103476B1 (fi) 1999-07-15
EP0463877A1 (fr) 1992-01-02
HU214590B (hu) 1998-04-28
DK0463877T3 (da) 1994-06-27
AU7924391A (en) 1992-01-02
FI912952A0 (fi) 1991-06-18
ATE106241T1 (de) 1994-06-15
JP2558396B2 (ja) 1996-11-27
KR0133511B1 (ko) 1998-04-23
HUT59321A (en) 1992-05-28
EP0463877B1 (fr) 1994-06-01
FI103476B (fi) 1999-07-15
US5137733A (en) 1992-08-11
DE69102211T2 (de) 1994-09-15
ES2055962T5 (es) 1997-09-16
IE64629B1 (en) 1995-08-23
DE69102211D1 (de) 1994-07-07
EP0463877B2 (fr) 1997-07-02
CN1040061C (zh) 1998-10-07
GR3024471T3 (en) 1997-11-28
IL98611A0 (en) 1992-07-15
CA2045358A1 (fr) 1991-12-29
KR920000313A (ko) 1992-01-29
IE912166A1 (en) 1992-01-01
IL98611A (en) 1998-10-30

Similar Documents

Publication Publication Date Title
IL98611A0 (en) Controlled release pharmaceutical preparation
PH22119A (en) Controlled release medical preparations
EP0213083A3 (fr) Comprimé à libération contrôlée
AU6798890A (en) Controlled release pharmaceutical preparation and method for producing the same
CA2304110A1 (fr) Comprime de theophylline a liberation prolongee
AR244089A1 (es) Metodo para la obtencion de una preparacion farmaceutica de liberacion sostenida.
CA2175122A1 (fr) Systeme therapeutique transdermique a liberation prolongee
DE3874360D1 (de) Kugelfoermige granula mit kern sowie deren herstellung.
DE69624047D1 (de) Im unteren Teil des Verdauungstrakts freisetzende pharmazeutische Zubereitung in Form einer beschichteten Kapsel
ATE67408T1 (de) Arzneimittel mit verzoegerter freigabe in oraler dosisform.
IL87986A0 (en) Controlled release vegetation enhancement agents coated with sulfonated polymers,their production and their use
CA2121038A1 (fr) Preparation orale pour liberation dans le tractus gastro-intestinal inferieur
FI973107A0 (fi) Hallitusti vapautuvat vesiympäristön ravintoaineet
DE3889711D1 (de) Oberflächenbehandlung eines PET-Filmes.
IL97304A0 (en) Water soluble salts of purpuromycin and pharmaceutical formulations thereof
IL100529A0 (en) Chiral polymers,their preparation and their application in the preparation of optically active 2-arylpropionic acids
CA2124425A1 (fr) Comprimes pharmaceutiques liberant la substance active apres une periode de temps definie
BR8705086A (pt) Remanejo e retencao da enchente com liberacao-controlada da agua